Synthesis of ophthalmic acid in liver and kidney in vivo

Abstract

The synthesis of ophthalmic acid, an analogue of glutathione, was studied in vivo in mouse liver and kidney after administration of either L-α-aminobutyrate or L-γ-glutamyl-L-α-aminobutyrate as precursor. L-α-Aminobutyrate accumulated to a much greater extent, and induced a much greater synthesis of ophthalmic acid in the liver than in the kidney. In contrast, L-γ-glutamyl-L-α-aminobutyrate initiated a large and more rapid synthesis of ophthalmic acid in the kidney than in the liver. Experiments with L-γ-[G-14C]glutamyl-L-α-aminobutyrate showed that, although part of the dipeptide is degraded to its constituent amino acids, a significant proportion is directly incorporated into kidney ophthalmic acid. In contrast L-γ-glutamyl-L-α-aminobutyrate serves poorly as a direct precursor of liver ophthalmic acid. The present results show that kidney γ-glutamyl tripeptide synthesis can proceed directly from an exogenous γ-glutamyl dipeptide precursor.